An outbreak of concurrent echovirus 30 and coxsackievirus A1 infections associated with sea swimming among a group of travelers to Mexico.
暂无分享,去创建一个
J. Hadler | M. Pallansch | E. Begier | M. Oberste | W. A. Nix | M. Landry | D. Ferguson | M. Cartter | Kasia Frenette | P. Mshar | A. Nepaul | T. Brennan | T. Rabatsky-Ehr | D. Mlynarski | K. Purviance | Terry Rabatsky-Ehr
[1] Patricia Muñoz,et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] J. Wingard,et al. Changes in causes of death over time after treatment for invasive aspergillosis , 2008, Cancer.
[3] J. Perfect,et al. When primary antifungal therapy fails. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] J. Wingard. Learning from our failures: the antifungal treatment conundrum. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] H. Macapinlac,et al. The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. , 2008, Medical mycology.
[6] T. Hohl,et al. Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. , 2007, The Journal of infectious diseases.
[7] J. Wagner,et al. A scheme for defining cause of death and its application in the T cell depletion trial. , 2007, Biology of Blood and Marrow Transplantation.
[8] B. Barlogie,et al. Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis , 2007, Cancer.
[9] B. Barlogie,et al. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications , 2007, Cancer.
[10] J. Perfect,et al. Immune reconstitution syndrome associated with opportunistic mycoses. , 2007, The Lancet. Infectious diseases.
[11] J. Perfect,et al. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] D. Kontoyiannis,et al. Pretreatment with Empty Liposomes Attenuates the Immunopathology of Invasive Pulmonary Aspergillosis in Corticosteroid-Immunosuppressed Mice , 2006, Antimicrobial Agents and Chemotherapy.
[13] K. Sepkowitz,et al. Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] Mark A Pallansch,et al. Morbidity and Mortality Weekly Report Editorial and Production Staff Vol. 55 / Ss-8 Surveillance Summaries 1 Enterovirus Surveillance — United States, 1970–2005 , 2022 .
[15] M. Pallansch,et al. Sensitive, Seminested PCR Amplification of VP1 Sequences for Direct Identification of All Enterovirus Serotypes from Original Clinical Specimens , 2006, Journal of Clinical Microbiology.
[16] J. Fine,et al. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] G. Fink,et al. A Drug-Sensitive Genetic Network Masks Fungi from the Immune System , 2006, PLoS pathogens.
[18] F. Dromer,et al. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis , 2006, AIDS.
[19] D. Kontoyiannis,et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). , 2006, Haematologica.
[20] R. Rubin,et al. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] M. Pallansch,et al. Enterovirus molecular detection and typing , 2005 .
[22] B. Alexander,et al. Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] F. Dromer,et al. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France , 2005, AIDS.
[24] S. Shelburne,et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] M. Pallansch,et al. Enteroviruses 76, 89, 90 and 91 represent a novel group within the species Human enterovirus A. , 2005, The Journal of general virology.
[26] C. Montagnoli,et al. Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4. , 2005, The Journal of antimicrobial chemotherapy.
[27] S. Cesaro,et al. Combination antifungal therapy for invasive aspergillosis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] M. Czuczman,et al. Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: Clinical, radiologic, and pathologic characteristics , 2005, Mycopathologia.
[29] S. Diedrich,et al. An outbreak of viral meningitis associated with a public swimming pond , 2004, Epidemiology and Infection.
[30] D. Denning,et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] M. Pallansch,et al. Molecular identification and characterization of two proposed new enterovirus serotypes, EV74 and EV75. , 2004, The Journal of general virology.
[32] C. Viscoli. Combination therapy for invasive aspergillosis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] S. Balajee,et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. , 2004, The Journal of infectious diseases.
[34] E. Estey,et al. β-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome , 2004 .
[35] N. White,et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial , 2004, The Lancet.
[36] C. Yiannoutsos,et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] W. Leisenring,et al. Cyclophosphamide metabolism is affected by azole antifungals. , 2004, Blood.
[38] J. Hadler,et al. Aseptic meningitis outbreak associated with echovirus 9 among recreational vehicle campers--Connecticut, 2003. , 2004, MMWR. Morbidity and mortality weekly report.
[39] C. Baker,et al. Red book®: 2003 report of the committee on infectious diseases. , 2016 .
[40] H. Fricker-Hidalgo,et al. Detection of Circulating Aspergillus fumigatus Galactomannan: Value and Limits of the Platelia Test for Diagnosing Invasive Aspergillosis , 2003, Journal of Clinical Microbiology.
[41] J. Perfect,et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] J. Powers,et al. Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] J. Powers,et al. Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[44] J. Powers,et al. Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] M. Pallansch,et al. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[46] A. Bruu,et al. Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses and Newer Enteroviruses , 2003 .
[47] M. Landry,et al. Rapid Enterovirus RNA Detection in Clinical Specimens by Using Nucleic Acid Sequence-Based Amplification , 2003, Journal of Clinical Microbiology.
[48] J. Gerberding,et al. Outbreaks of aseptic meningitis associated with echoviruses 9 and 30 and preliminary surveillance reports on enterovirus activity--United States, 2003. , 2003, MMWR. Morbidity and mortality weekly report.
[49] J. Perfect,et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. , 2002, The New England journal of medicine.
[50] D. Beek,et al. Dexamethasone in adults with bacterial meningitis , 2002 .
[51] Richard Sylvester,et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.
[52] D. Bamberger,et al. Safety and Efficacy of Liposomal Amphotericin B Compared with Conventional Amphotericin B for Induction Therapy of Histoplasmosis in Patients with AIDS , 2002, Annals of Internal Medicine.
[53] B. François,et al. Invasive Aspergillosis in Allogeneic Stem Cell Transplant Recipients: Increasing Antigenemia Is Associated with Progressive Disease , 2002 .
[54] R. Hafner,et al. Antigen Clearance during Treatment of Disseminated Histoplasmosis with Itraconazole versus Fluconazole in Patients with AIDS , 2002, Antimicrobial Agents and Chemotherapy.
[55] D. Denning,et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[56] M. Mulders,et al. Viral water contamination as the cause of aseptic meningitis outbreak in Belarus. , 2001, Central European journal of public health.
[57] J. Verhaegen,et al. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. , 2001, Blood.
[58] A. Bernard,et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[59] A. Catanzaro,et al. Comparison of Oral Fluconazole and Itraconazole for Progressive, Nonmeningeal Coccidioidomycosis , 2000, Annals of Internal Medicine.
[60] Paul L. Williams,et al. Practice Guidelines for the Treatment of Coccidioidomycosis , 2000 .
[61] J. Perfect,et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[62] W. Ledermann,et al. Randomized trial of four vs. seven days of ceftriaxone treatment for bacterial meningitis in children with rapid initial recovery , 2000, The Pediatric infectious disease journal.
[63] O. Lehtonen,et al. Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome. , 2000, Scandinavian journal of infectious diseases.
[64] J. Cleary,et al. Amphotericin B-induced interleukin-1beta expression in human monocytic cells is calcium and calmodulin dependent. , 1999, The Journal of infectious diseases.
[65] C. Brisson,et al. Job strain and pregnancy-induced hypertension. , 1999, Epidemiology.
[66] J S Witte,et al. The health effects of swimming in ocean water contaminated by storm drain runoff. , 1999, Epidemiology.
[67] G. Mccracken,et al. Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group. , 1999, The Pediatric infectious disease journal.
[68] S. Solomon,et al. Viral meningitis in child care center staff and parents: an outbreak of echovirus 30 infections. , 1999, Public health reports.
[69] M. Saag,et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[70] A. Prüss. Review of epidemiological studies on health effects from exposure to recreational water. , 1998, International journal of epidemiology.
[71] M. Saag,et al. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. , 1997, The American journal of medicine.
[72] M. Saag,et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. , 1997, The New England journal of medicine.
[73] K. Kawakami,et al. Anticryptococcal effect of amphotericin B is mediated through macrophage production of nitric oxide , 1996, Antimicrobial agents and chemotherapy.
[74] J. Galgiani,et al. Is It Ever Safe To Stop Azole Therapy for Coccidioides immitis Meningitis? , 1996, Annals of Internal Medicine.
[75] K. Kliche,et al. Infusion‐related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels , 1995, Mycoses.
[76] J. Serody,et al. Intravascular Catheter Exchange and Duration of Candidemia , 1995 .
[77] R. Dagan,et al. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group , 1995, Antimicrobial agents and chemotherapy.
[78] F. Hecht,et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. , 1995, The American journal of medicine.
[79] G. Mccracken,et al. Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children , 1995, Antimicrobial agents and chemotherapy.
[80] J. Galgiani,et al. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. , 1995, The American journal of medicine.
[81] A. Favero,et al. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature , 1995, British journal of haematology.
[82] F. Kee,et al. A community outbreak of echovirus infection associated with an outdoor swimming pool. , 1994, Journal of public health medicine.
[83] M. Pallansch,et al. Echovirus 30 infection and aseptic meningitis in parents of children attending a child care center. , 1994, The Journal of infectious diseases.
[84] J. Galgiani,et al. Fluconazole Therapy for Coccidioidal Meningitis , 1993, Annals of Internal Medicine.
[85] M. Pallansch,et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[86] B. Katz,et al. Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. , 1991, Annals of internal medicine.
[87] K. Olsen,et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. , 1991, The New England journal of medicine.
[88] H. Rotbart. Nucleic acid detection systems for enteroviruses , 1991, Clinical Microbiology Reviews.
[89] J. Galgiani,et al. Itraconazole treatment of coccidioidomycosis , 1990 .
[90] R. M. Tucker,et al. Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations. , 1990, Journal of the American Academy of Dermatology.
[91] M. Salimans,et al. Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.
[92] R. M. Tucker,et al. Itraconazole therapy for chronic coccidioidal meningitis. , 1990, Annals of internal medicine.
[93] G. Potente. CT findings in fungal opportunistic pneumonias: body and brain involvement. , 1989, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.
[94] D. Lenaway,et al. An outbreak of an enterovirus-like illness at a community wading pool: implications for public health inspection programs. , 1989, American journal of public health.
[95] S. Lipson,et al. Sensitivity of rhabdomyosarcoma and guinea pig embryo cell cultures to field isolates of difficult-to-cultivate group A coxsackieviruses , 1988, Journal of clinical microbiology.
[96] J. Galgiani,et al. Ketoconazole therapy of progressive coccidioidomycosis. Comparison of 400- and 800-mg doses and observations at higher doses. , 1988, The American journal of medicine.
[97] L. Anderson,et al. Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. , 1986, The Journal of infectious diseases.
[98] S. Albelda,et al. Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemia. , 2015, The American review of respiratory disease.
[99] W. Gefter,et al. Invasive pulmonary aspergillosis and acute leukemia. Limitations in the diagnostic utility of the air crescent sign. , 1985, Radiology.
[100] E. H. Lennette. Laboratory diagnosis of viral infections , 1985 .
[101] K. R. Ratzan. Viral meningitis. , 1985, The Medical clinics of North America.
[102] D. Stevens,et al. Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis. , 1983, The American journal of medicine.
[103] C. Madeley. FATAL DIARRHOEA AND COXSACKIE A1 VIRUS , 1982, The Lancet.
[104] R. Yolken,et al. OUTBREAK OF COXSACKIE A1 GASTROENTERITIS: A COMPLICATION OF BONE-MARROW TRANSPLANTATION , 1982, The Lancet.
[105] E. H. Lennette,et al. Propagation and isolation of group A coxsackieviruses in RD cells , 1975, Journal of clinical microbiology.
[106] C. A. Phillips,et al. Coxsackievirus B epidemic at a Boy's Summer Camp. Isolation of virus from swimming water. , 1973, JAMA.
[107] J. Enders,et al. Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.
[108] W. B. King. THE LABORATORY DIAGNOSIS OF VIRAL INFECTIONS. , 1964, Maryland state medical journal.
[109] W. Schaffner,et al. The diarrhea of travelers. IV. Viral studies of visiting students in Mexico with further bacteriologic and parasitologic observations. , 1963, The American journal of tropical medicine and hygiene.
[110] Gelfand Hm. The occurrence in nature of the Coxsackie and ECHO viruses. , 1961 .
[111] H. Gelfand. The occurrence in nature of the Coxsackie and ECHO viruses. , 1961, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.
[112] B. Kean,et al. The diarrhea of travelers. III. Drug prophylaxis in Mexico. , 1959, The New England journal of medicine.